MSD ANIMAL HEALTH PARTNERS WITH FIRST WATER OF ICELAND TO DEPLOY FALCON™ BIOMASS

MSD Animal Health partners with First Water of Iceland to deploy FALCON™ Biomass. MSD Animal Health Norway, has announced that it has signed an agreement to partner with First Water hf., formerly known as Landeldi hf., a company working towards developing land-based fish farming in Þorlákshöfn, Iceland. Developed with over 25 years of experience in the measurement of fish in sea net pens, vision technology FALCON Biomass is set to change the way fish are measured and monitored in land-based aquaculture operations.

The FALCON Biomass system combines advanced vision technology with years of research and development, resulting in a state-of-the-art solution that delivers key insights to our customers. Leveraging the expertise and knowledge gained from working on vision technology, artificial intelligence, and biomass measurements, MSD Animal Health launched the FALCON Biomass at Aquanor 2023 in Trondheim, Norway. This new system has since been implemented in sea net pens across Norway, Chile, and the UK.

“The sale of the FALCON Biomass system to First Water is a significant milestone for MSD Animal Health. We are thrilled to partner with a progressive and forward-thinking organisation that shares our vision for sustainable aquaculture,” said Dafydd Morris, General Manager of MSD Animal Health Aqua Europe. “This alliance not only strengthens our position as a global leader in aquaculture technology but also paves the way for the adoption of vision technology in the land-based fish farming sector.”

The FALCON Biomass system offers numerous advantages over traditional fish measurement methods. By utilising vision technology, the system provides near real-time data on average weight, size distribution and overall biomass. “This provides the farmer with greater insight, allowing for optimised decision making in production and harvest planning. We are proud that First Water have chosen us as their trusted partner to take care of their biomass estimation needs”, said Bertil Storvik, Sea Based Solutions Lead, MSD Animal Health Aqua Europe.

“We are excited to integrate the FALCON Biomass system into our land-based fish farm. This technology will enable us to monitor more accurately the growth of our fish population, ensuring their well-being and allowing us to make data-driven decisions,” said Kristinn Marinósson, First Water. “We believe that this solution will contribute to the sustainable development and expansion of our operations, while further solidifying Iceland’s position as a leader in the aquaculture industry.”

The FALCON Biomass system is set to continue to expand its presence globally, with plans to expand to new markets in Canada, Ireland, and the Faroe Islands.

For more information about the FALCON Biomass system, please visit www.aquafalcon.com

About MSD Animal Health

At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are unified around our purpose: They use the power of leading-edge science to save and improve lives around the world. For more than a century, they’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com and connect with them on LinkedIn and X (formerly Twitter).

MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., Rahway, NJ., U.S.A. Through their prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. They also demonstrate their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.msd.com